TOMTOM
10.11.2015 07:31:20 CET | Business Wire | Press release
TomTom Telematics and Shell cooperate to offer businesses in Europe a complete fuel management solution using the TomTom Telematics fleet management platform WEBFLEET alongside Shell fuel management services.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151109006095/en/
As a result of this agreement, TomTom Telematics will launch a service that integrates euroShell Cards data into its WEBFLEET platform, making fuel transactions and fuel management information available for users in one system.
“TomTom Telematics has a strong portfolio and high performance standards to help fleets improve fuel efficiency, which fits well with the expectations of Shell customers,” said Thomas Schmidt, Managing Director at TomTom Telematics.
“Furthermore, the integration of euroShell Cards fuel data within WEBFLEET provides a more complete picture for fleet managers, enabling them to optimise and manage all aspects of fuel efficiency.”
Parminder Kohli, General Manager Business Development at Shell Commercial Fleet, added: “This deal provides customers with a complete solution combining one of the telematics industry’s richest reporting suites with Shell’s fuel card expertise and one of the largest petrol station networks in Europe.”
“Fuel is amongst the biggest cost factors when running a vehicle fleet. However, by providing businesses with driver, vehicle and fuelling data insights, areas for improvement can be more easily identified and acted on, helping these businesses to reduce their costs and carbon footprint.”
-ENDS-
About TomTom
At TomTom (TOM2) our mission is to make technology so easy to use, that everyone can benefit from it.
We created easy to use navigation devices, helping millions of people to get where they want to be. Today, we continue to simplify the complex, making technology more accessible for everyone.
We have four customer facing business units: Consumer, Telematics, Automotive and Licensing.
We make easy to use navigation devices, sport watches and action cameras for consumers. We enable businesses with vehicles to more easily manage and improve fleet efficiency whilst increasing overall business performance with our Telematics solutions. We also offer a world leading real-time map platform that is powering innovative location based services and helping to make automated driving a reality for the automotive industry.
Founded in 1991 and headquartered in Amsterdam, we have over 4,400 employees worldwide and sell our products in 48 countries.
About TomTom Telematics
TomTom Telematics is a Business Unit of TomTom dedicated to fleet management and vehicle telematics. Our WEBFLEET platform is a Software-as-a-Service solution – used by small to large businesses to improve vehicle performance, save fuel, support drivers and increase overall fleet efficiency.
TomTom Telematics is one of the world’s leading telematics solution providers with now over 500,000 subscriptions worldwide. We service drivers in more than 60 countries, giving them the industry’s strongest local support network and widest range of sector-specific 3rd party applications and integrations. More than 36,000 customers benefit every day from a high standard of security, quality and availability of our ISO 27001:2013 certified service, re-audited in June 2015.
For further information, please visit http://business.tomtom.com/
Follow us on Twitter @TomTomBusiness
View source version on businesswire.com: http://www.businesswire.com/news/home/20151109006095/en/
Contact:
TomTom
Global Press Office:
Sarah Schweiger
Global
PR Manager
sarah.schweiger@tomtom.com
or
Investor
Relations:
Bisera Grubesic
Head of Treasury and Investor
Relations
+31 (0)20 757 5194
ir@tomtom.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom